You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Colorcon
Johnson and Johnson
Dow
Moodys

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

TOLTERODINE TARTRATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Tolterodine Tartrate patents expire, and when can generic versions of Tolterodine Tartrate launch?

Tolterodine Tartrate is a drug marketed by Ajanta Pharma Ltd, Hetero Labs Ltd Iii, Inventia Hlthcare, Mylan, Teva Pharms Usa, Torrent, Apotex Corp, Invatech, Ivax Sub Teva Pharms, Macleods Pharms Ltd, Mylan Pharms Inc, and Unique Pharm Labs. and is included in twelve NDAs.

The generic ingredient in TOLTERODINE TARTRATE is tolterodine tartrate. There are twenty-three drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the tolterodine tartrate profile page.

US ANDA Litigation and Generic Entry Outlook for Tolterodine Tartrate

A generic version of TOLTERODINE TARTRATE was approved as tolterodine tartrate by MYLAN on October 31st, 2013.

  Start Trial

Drug patent expirations by year for TOLTERODINE TARTRATE
Drug Prices for TOLTERODINE TARTRATE

See drug prices for TOLTERODINE TARTRATE

Drug Sales Revenue Trends for TOLTERODINE TARTRATE

See drug sales revenues for TOLTERODINE TARTRATE

Recent Clinical Trials for TOLTERODINE TARTRATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shanghai Institute of Acupuncture, Moxibustion and MeridianN/A
RenJi HospitalN/A
Federal University of São PauloPhase 4

See all TOLTERODINE TARTRATE clinical trials

Pharmacology for TOLTERODINE TARTRATE
Medical Subject Heading (MeSH) Categories for TOLTERODINE TARTRATE
Paragraph IV (Patent) Challenges for TOLTERODINE TARTRATE
Tradename Dosage Ingredient NDA Submissiondate
DETROL LA CAPSULE, EXTENDED RELEASE;ORAL tolterodine tartrate 021228 2007-07-30
DETROL TABLET;ORAL tolterodine tartrate 020771

US Patents and Regulatory Information for TOLTERODINE TARTRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ajanta Pharma Ltd TOLTERODINE TARTRATE tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 213397-001 May 19, 2020 AB RX No No   Start Trial   Start Trial   Start Trial
Ivax Sub Teva Pharms TOLTERODINE TARTRATE tolterodine tartrate TABLET;ORAL 077006-002 Feb 23, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
Unique Pharm Labs TOLTERODINE TARTRATE tolterodine tartrate TABLET;ORAL 204721-002 Jan 24, 2020 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Boehringer Ingelheim
Moodys
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.